Subscribe To
Aligos therapeutics announces research collaboration and development agreement with xiamen amoytop biotech co. ltd. for use of aligos’ oligonucleotide platform for the treatment of liver diseases
SOUTH SAN FRANCISCO, Calif., May 12, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical s...
May 12, 2023, 9:05 pm